DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte Corporation 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Bristol-Myers Squibb Company 

Amersham Biosciences 

PanVera LLC 

Rigel Pharmaceuticals, Inc. 

Massachusetts Life Sciences Center 





 Company News
Johnson & Johnson (JNJ) May Shell Out $250 Million To Settle 1,000 More Hip Claims 10/31/2014 6:27:58 AM
Johnson & Johnson (JNJ) Diabetes Solutions Companies Join The Joslin Institute For Technology Translation (JITT) As Founding Members 10/30/2014 11:10:31 AM
Johnson & Johnson (JNJ) Launches Shanghai R&D Hub And Announces New Alliances 10/29/2014 6:03:57 AM
Ex-Johnson & Johnson (JNJ) Exec Named CEO And President Of Alere Inc. (ALR) 10/28/2014 6:42:33 AM
Johnson & Johnson (JNJ)'s DePuy Orthopaedics, Inc. (JNJ) Wins First Trial Over Pinnacle Hips 10/24/2014 7:07:32 AM
Johnson & Johnson (JNJ) To Launch J-Labs Incubator At Houston’s TMC To Boost Biotechs 10/23/2014 6:30:54 AM
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses 10/22/2014 6:16:58 AM
Johnson & Johnson (JNJ) Pledges $200 Million To Ebola, Will Begin Testing Vaccine In January 2015 10/22/2014 5:45:21 AM
Johnson & Johnson (JNJ) Continues To Pay Hefty Integration Charges On Synthes, Inc. (SYST) Buy 10/17/2014 7:07:22 AM
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/15/2014 6:04:15 AM
12345678910...